MiMedx is planning a U.S. launch for a next-generation lyophilized version of OrthoFlo, its amniotic fluid-based allograft for use in in orthopaedic and sports-medicine applications. Â
Study results suggest that AMNIOX Medical’s CLARIX®  FLO and CLARIX® CORD 1K regenerative therapies improved outcomes in plantar fasciitis treatment and tarsal coalition repair.
Since mid-May, both Medtronic and Zimmer Biomet have announced strategic moves in the 2-level cervical disc replacement and robotic surgery markets. In efforts to invigorate revenue growth, the two have focused on niche technologies that should expand their portfolios-but have yet to prove wide scale.
Stryker Performance Solutions launched Episode Performance Manager™, a digital tool to translate raw claims data provided by Medicare into dynamic reports to compare performance of hospitals participating in the Comprehensive Care for Joint Replacement initiative.
Medtronic received FDA 510(k) clearance to market the CD Horizon® Fenestrated Screw Set, indicated for treatment of advanced stage tumors in the thoracic and lumbar spine.
DePuy Synthes trauma commenced global launch of the Variable Angle Locking Hand System, comprising anatomically-contoured and low-profile plates to treat hand fractures and to correct deformities.Â
Zimmer Biomet announced its plans to acquire Medtech, provider of surgical systems including the ROSA™ Spine robotic-assistive device for minimally invasive surgery.